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Background: Methylarginines (such as asymmetric [ADMA] and symmetric [SDMA] dimethylarginines) are endogenous inhibitors of nitric oxide 
(NO) synthases and/or intracellular arginine uptake, thereby reducing NO production and adversely impacting on heart failure (HF). We have recently 
demonstrated that raised intracardiac pressure is a major determinant of circulating methylarginine levels, but the underlying pathophysiologic 
mechanisms have not been elucidated.
Methods: We measured myocardial tissue levels of enzymes responsible for synthesis (PRMT-1) as well as degradation (DDAH-1 and DDAH-2) 
of methylarginines in left ventricle specimens from explanted human hearts. Subjects were divided into 3 groups: 1) Failing hearts with elevated 
intracardiac pressures (pulmonary capillary wedge pressure [PCWP]: 37-40 mmHg, “HF-H”, n=10); 2) Failing hearts without elevated PCWP (4-11 
mmHg, “HF-L”, n=10); and 3) Non-failing hearts (“controls”, n=10).
Results: Higher myocardial protein levels of PRMT1 are observed in HF-H compared to that of controls (2.9±2.0 versus 1.1 ± 0.3, p=0.01) and to 
that of HF-L (3.0 ± 1.8 versus1.0± 0.6, p=0.003). Further, significantly higher myocardial protein levels of DDAH-1 are observed in HF-L compared 
to that of control hearts (1.6± 1.0 versus 0.7±0.5, p=0.02). DDAH-1 protein levels were lower in myocardial tissues associated with higher PCWP 
(1.6±1.0 versus 0.9±0.5, p=0.03), while myocardial DDAH-2 protein levels were similar across the 3 groups.
Conclusion: Increased myocardial PRMT-1 levels and diminished compensatory DDAH-1 levels in the setting of HF are associated with raised 
intracardiac pressures. These findings provide direct evidence that adaptation/maladaptation associated with increased circulating methylarginine 
levels is present in the human failing myocardium.
